| Description | Coblopasvir is a pan-genotypic non-structural protein 5A (NS5A) inhibitor. It can be used to study chronic hepatitis C virus infection. |
| molecular weight | 782.88 |
| Molecular formula | C41H50N8O8 |
| CAS | 1312608-46-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Gao Y, Kong F, et al. Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial. Liver Int. 2020 Nov;40(11):2685-2693. |